Furthermore, IFN-γ-induced activation of IDO in MSCs can create a Trp-depleted milieu that promotes immunosuppression and ameliorates experimental autoimmune encephalomyelitis (EAE), an animal model of MS [20], [22], [23]. Here, IDO1 is linked to myeloid sarcoma.